David A Reardon Selected Research

David A Reardon Research Topics

Disease

159	Glioblastoma (Glioblastoma Multiforme) 11/2022 - 01/2004
147	Neoplasms (Cancer) 05/2022 - 05/2002
89	Glioma (Gliomas) 01/2021 - 03/2002
41	Brain Neoplasms (Brain Tumor) 01/2022 - 10/2003
10	Meningioma (Meningiomas) 01/2022 - 01/2012
9	Melanoma (Melanoma, Malignant) 12/2021 - 04/2006
9	Fatigue 10/2019 - 12/2010
8	Disease Progression 12/2021 - 01/2012
6	Diarrhea 01/2018 - 01/2004
5	Astrocytoma (Pilocytic Astrocytoma) 10/2019 - 01/2006
5	Hemorrhage 01/2018 - 10/2009
5	Lymphopenia (Lymphocytopenia) 09/2014 - 06/2010
4	Oligodendroglioma 05/2022 - 01/2006
4	Residual Neoplasm 10/2019 - 11/2010
4	Thrombocytopenia (Thrombopenia) 09/2014 - 04/2003
3	Hypoxia (Hypoxemia) 01/2021 - 12/2010
3	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2018
3	Edema (Dropsy) 01/2021 - 02/2017
3	Gliosarcoma 01/2020 - 01/2006
3	Hypertension (High Blood Pressure) 10/2019 - 01/2013
3	Lymphoma (Lymphomas) 01/2014 - 01/2013

Drug/Important Bio-Agent (IBA)

57	Temozolomide (Temodar)FDA LinkGeneric 11/2022 - 02/2003
52	Bevacizumab (Avastin)FDA Link 01/2021 - 02/2007
28	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2004
20	Monoclonal AntibodiesIBA 11/2017 - 03/2002
18	Immune Checkpoint InhibitorsIBA 11/2022 - 09/2015
18	VaccinesIBA 01/2021 - 05/2008
18	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 02/2008
18	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 05/2003
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2011
15	epidermal growth factor receptor VIIIIBA 01/2022 - 10/2009
13	NivolumabIBA 11/2022 - 09/2015
13	Pharmaceutical PreparationsIBA 11/2020 - 08/2010
11	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 04/2010
11	Tyrosine Kinase InhibitorsIBA 01/2018 - 01/2004
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2006
9	AntigensIBA 01/2020 - 09/2004
9	CilengitideIBA 05/2018 - 08/2008
8	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 01/2017
8	Phosphotransferases (Kinase)IBA 11/2019 - 01/2005
8	IntegrinsIBA 05/2018 - 08/2008
7	TOR Serine-Threonine KinasesIBA 11/2019 - 01/2005
7	Angiogenesis InhibitorsIBA 06/2017 - 04/2010
7	Carmustine (FIVB)FDA Link 11/2014 - 05/2002
6	IpilimumabIBA 12/2021 - 09/2015
6	pembrolizumabIBA 01/2021 - 09/2015
6	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018 - 01/2005
6	EnzymesIBA 02/2013 - 02/2006
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2012 - 01/2010
6	Imatinib Mesylate (Gleevec)FDA Link 10/2012 - 12/2005
6	O(6)-benzylguanineIBA 10/2009 - 05/2002
5	B7-H1 AntigenIBA 01/2022 - 03/2015
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 11/2017
5	DNA (Deoxyribonucleic Acid)IBA 05/2018 - 05/2008
5	Biological ProductsIBA 01/2017 - 01/2012
5	Anticonvulsants (Antiepileptic Drugs)IBA 03/2016 - 02/2006
5	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2012 - 12/2005
5	Peptides (Polypeptides)IBA 01/2012 - 05/2008
4	Lomustine (CCNU)FDA Link 05/2022 - 11/2014
4	LigandsIBA 01/2021 - 02/2016
4	CytokinesIBA 01/2021 - 01/2012
4	InterferonsIBA 01/2020 - 01/2018
4	AntibodiesIBA 10/2018 - 02/2016
4	MethyltransferasesIBA 05/2018 - 08/2013
4	cabozantinibIBA 01/2018 - 02/2016
4	Cytotoxins (Cytolysins)IBA 11/2015 - 02/2007
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2012 - 11/2005
4	Immunotoxins (Immunotoxin)IBA 09/2011 - 01/2005
3	AfatinibIBA 01/2022 - 03/2015
3	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2015
3	SteroidsIBA 01/2021 - 01/2005
3	rindopepimutIBA 01/2020 - 01/2015
3	EpitopesIBA 01/2019 - 01/2018
3	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 07/2017
3	Carboplatin (JM8)FDA LinkGeneric 01/2019 - 12/2011
3	depatuxizumab mafodotinIBA 01/2019 - 12/2017
3	Messenger RNA (mRNA)IBA 11/2016 - 04/2006
3	O(6)-Methylguanine-DNA MethyltransferaseIBA 05/2015 - 05/2002
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015 - 02/2006
3	Alkylating AgentsIBA 08/2013 - 05/2003
3	Sirolimus (Rapamycin)FDA Link 11/2012 - 02/2006
3	AEE 788 (AEE788)IBA 06/2012 - 01/2005
3	Adenosine Triphosphate (ATP)IBA 05/2012 - 12/2005
3	Everolimus FDA Link 01/2012 - 01/2005
3	Human Serum Albumin FDA LinkGeneric 09/2011 - 03/2007
3	Topoisomerase I InhibitorsIBA 10/2005 - 04/2004
2	Procarbazine (Matulane)FDA Link 05/2022 - 12/2017
2	Vincristine (Oncovin)FDA LinkGeneric 05/2022 - 12/2017
2	Interleukin-12 (IL 12)IBA 01/2022 - 01/2019

Therapy/Procedure

105	Therapeutics 01/2022 - 01/2005
42	Immunotherapy 01/2022 - 09/2004
37	Radiotherapy 11/2022 - 06/2005
30	Drug Therapy (Chemotherapy) 05/2022 - 04/2003
7	Chemoradiotherapy 11/2022 - 04/2010
7	Salvage Therapy 10/2018 - 02/2007
4	Radioimmunotherapy 05/2007 - 09/2005
3	Molecular Targeted Therapy 01/2021 - 02/2015
3	Drug Tapering 01/2018 - 01/2012
3	Re-Irradiation 12/2017 - 07/2016
3	Brachytherapy 09/2015 - 01/2006